DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded at Bank of America

Bank of America upgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a neutral rating to a buy rating in a research report sent to investors on Thursday, MarketBeat reports. Bank of America currently has $17.00 price objective on the medical instruments supplier’s stock, up from their previous price objective of $13.00.

Several other equities analysts also recently commented on XRAY. Mizuho upped their target price on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research report on Tuesday, January 20th. Wells Fargo & Company reduced their price target on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Friday, November 7th. Stifel Nicolaus set a $13.00 price objective on DENTSPLY SIRONA in a report on Thursday, November 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, January 21st. Finally, Barclays assumed coverage on shares of DENTSPLY SIRONA in a research report on Monday, December 8th. They issued an “underweight” rating and a $12.00 target price for the company. Three investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $14.46.

DENTSPLY SIRONA Trading Up 0.2%

Shares of XRAY opened at $12.54 on Thursday. The firm has a market capitalization of $2.50 billion, a price-to-earnings ratio of -2.84, a P/E/G ratio of 0.99 and a beta of 1.01. The stock’s 50-day moving average price is $12.23 and its 200 day moving average price is $12.48. DENTSPLY SIRONA has a 12-month low of $9.85 and a 12-month high of $19.27. The company has a quick ratio of 0.99, a current ratio of 1.47 and a debt-to-equity ratio of 1.36.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 26th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 annualized dividend and a dividend yield of 5.1%. DENTSPLY SIRONA’s payout ratio is -14.48%.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier sold 82,200 shares of the stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.50% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Eurizon Capital SGR S.p.A. acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in DENTSPLY SIRONA during the first quarter worth $26,000. Parkside Financial Bank & Trust lifted its holdings in DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 1,477 shares during the period. Huntington National Bank boosted its position in DENTSPLY SIRONA by 292.9% during the third quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 2,077 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its position in DENTSPLY SIRONA by 337.9% during the third quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 2,122 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

More DENTSPLY SIRONA News

Here are the key news stories impacting DENTSPLY SIRONA this week:

• Positive Sentiment: Bank of America upgraded XRAY from Neutral to Buy and raised its price target to $17 from $13 (about 35.6% upside vs. the current price). The upgrade is being cited as the primary catalyst for intraday gains. B of A Securities Upgrades DENTSPLY SIRONA (XRAY) Dentsply Sirona gains as BofA upgrades to Buy on risk-reward setup
• Neutral Sentiment: The company is expected to announce quarterly earnings on Thursday, which increases near-term volatility and focus on results vs. guidance. Investors should watch the report for revenue trends and margin commentary. DENTSPLY SIRONA (XRAY) Expected to Announce Earnings on Thursday
• Neutral Sentiment: Short-interest data reported in the last two days shows anomalous figures (zeros/NaN), suggesting a reporting error rather than a true surge in shorting; this makes short-interest-driven moves unlikely unless corrected data emerges.
• Negative Sentiment: A Zacks preview warns that XRAY lacks the setup for an earnings beat in the coming report, which could cap upside and lead to a pullback if results or guidance disappoint. Traders should weigh the upgrade optimism against this caution. Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.